NCT03237793

Brief Summary

The present study was designed as a randomised controlled clinical trial which was unicenter, double-blinded, parallel designed study, according to the Consolidated Standards of Reporting Trials (CONSORT) criteria, 2010. The study period was from July 2014 to September 2015.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2014

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2014

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

July 26, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 3, 2017

Completed
Last Updated

August 8, 2017

Status Verified

July 1, 2017

Enrollment Period

1.2 years

First QC Date

July 26, 2017

Last Update Submit

August 7, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Reduction in hypersensitivity

    The primary outcome that was assessed in the study was the reduction in dentinal hypersensitivity sensation. The visual analogue scale was used as a recording scale when tested with the tests for hypersensitivity, which were the testing with a blast of air, ice cold water testing and electrical tactile sensitivity testing using a scratch-o-meter.

    30 minutes

Secondary Outcomes (3)

  • use of diode laser in reducing hypersensitivity

    30 mins

  • use of desensitising agent alone

    30 minutes

  • combination of densensitising agent and diode laser

    30 minutes

Study Arms (2)

Fluorosed Group

ACTIVE COMPARATOR

45 patients for the fluorosis groupGROUP 1A: Patients with healthy fluorosed teeth receiving desensitising agent (potassium nitrate- RA Themoseal\*\*) treatment. (n=15) GROUP 1B: Patients with healthy fluorosed teeth receiving diode laser treatment$. (n=15) GROUP 1C: Patients with healthy fluorosed teeth receiving diode laser + desensitising agent (potassium nitrate- RA Thermoseal\*\*) treatment. (n=15)

Procedure: Fluorosed Group

Non Flourosed Group

PLACEBO COMPARATOR

45 patients for the non-fluorosis groupGROUP 2- Non Flourosed Group (n=45) GROUP 2A: Patients with healthy non fluorosed teeth receiving desensitising agent (potassium nitrate- RA Thermoseal\*\*) treatment. (n=15) GROUP 2B: Patients with healthy non fluorosed teeth receiving diode laser treatment. (n=15)GROUP 2C: Patients with healthy non fluorosed teeth receiving diode laser + desensitising agent (potassium nitrate- RA thermoseal\*\*) treatment. (n=15

Procedure: Non Flourosed Group

Interventions

A single episode of laser therapy with without potassium nitrate (RA Thermoseal\*) desensitising agent application was administered to the patients, A group only with desensitising paste and A group with desensitising paste and laser treatment depending on the study group they were assigned

Fluorosed Group

A single episode of laser† therapy with or without potassium nitrate (RA Thermoseal\*) desensitising agent application was administered to the patients, depending on the study group they were assignedGROUP 2B: Patients with healthy non fluorosed teeth receiving diode laser treatment$. (n=15)GROUP 2C: Patients with healthy non fluorosed teeth receiving diode laser + desensitising agent (potassium nitrate- RA thermoseal\*\*) treatment.

Non Flourosed Group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with a positive response for hypersensitivity testing (Pashley, 1990) i.e. cold water testing using ice cold water (Trowbridge et al., 1980),
  • Air blow test (Coleman and Kinderknecht, 2000),
  • Electric tactile stimulation test (Camps and Pashley, 2003),
  • Patients presenting with non-carious cervical lesions in the enamel (Loomba et al., 2013), fluorosed teeth wherein fluorotic enamel staining confirmed by clinical examination, healthy non fluorosed teeth, which was confirmed by clinical examination (Dean, 1934).

You may not qualify if:

  • Patients undergoing any form of restorative endodontic,
  • Orthodontic treatment or crown restorations,
  • Local defects including caries and fractures,
  • Presence of any systemic diseases,
  • Acute pain conditions (like apical periodontitis, periapical abscess),
  • Presence of periodontal disease or a history of periodontal treatment in last 6 months,
  • Usage of desensitising toothpaste or mouth rinse in the last 4 weeks,
  • Patients allergic to ingredients used in the study product,
  • Teeth with intrinsic stains caused by other reasons.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Fluorosis, DentalDentin Sensitivity

Condition Hierarchy (Ancestors)

Dental Enamel HypomineralizationDevelopmental Defects of EnamelTooth AbnormalitiesStomatognathic System AbnormalitiesStomatognathic DiseasesTooth DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Rashmi Paramashivaiah, MDS

    Krishnadevaraya college of dental sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
A unified stratified randomization, double blind controlled parallel designed was the type generated the allocation sequence. A skilled assistant enrolled the participants and assigned the participants to interventions.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The present study was designed as a randomised controlled clinical trial which was unicenter, double-blinded, parallel designed study, according to the Consolidated Standards of Reporting Trials (CONSORT) criteria, 2010.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 26, 2017

First Posted

August 3, 2017

Study Start

July 1, 2014

Primary Completion

September 1, 2015

Study Completion

September 1, 2015

Last Updated

August 8, 2017

Record last verified: 2017-07